SEC Filing Summary: Form 8-K
Business Context and Reporting Period
Company: The Beauty Health Company (trading as Skinhealth Systems Inc., ticker: SKIN)
Filing Date: March 3, 2026
Reporting Period: Current report regarding events occurring on February 9, 2026, and February 20, 2026.
The filing addresses a legal settlement regarding a consolidated stockholder derivative action pending in the Delaware Court of Chancery (Elstein v. Saunders et al.).
Key Financial Metrics
This Form 8-K does not contain financial performance data. The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity.
Material Changes
- Legal Settlement: On February 9, 2026, parties to the Consolidated Derivative Action entered into a Stipulation of Settlement to resolve all claims described in Note 6 of the Company's Condensed Consolidated Financial Statements for the period ended September 30, 2025.
- Court Order: On February 20, 2026, the Delaware Court of Chancery entered a Scheduling Order requiring the Company to file a Notice of Pendency and Proposed Settlement as an exhibit to this 8-K.
Guidance, Outlook, and Risks
Contingencies: The settlement is subject to court approval. The full description of the settlement is qualified by reference to the Stipulation and the Notice of Pendency (Exhibit 99.1).
Management Commentary: The filing directs investors to the Company's website (legal-notices page) for the full text of the Stipulation and Notice.
Risks: The resolution of the derivative action remains contingent upon judicial approval.
Investor Verification Checklist
- Verify the final terms of the Stipulation of Settlement in Exhibit 99.1.
- Confirm the date and outcome of the Settlement Hearing scheduled by the Delaware Court of Chancery.
- Review Note 6 of the Form 10-Q filed on November 6, 2025, to understand the specific claims being resolved.
- Monitor the Company's website for updates on the court's approval status.